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Abstract 
Medical device software organisations face challenges not faced by generic software devel-
opment organisations. These challenges include the adherence to regulatory controls. Regula-
tory bodies require medical device software organisations to provide objective evidence that 
the software they are developing is safe and reliable. To produce this, regulatory bodies re-
quire a number of deliverables which must be achieved. However, they do not dictate which 
Software Development Life Cycle (SDLC) must be followed in order to achieve these deliver-
ables. Despite not dictating which SDLC must be followed when developing medical device 
software, organisations typically develop their software in accordance with a Plan-Driven soft-
ware development lifecycle. By conducting semi structured interviews with seven medical de-
vice software organisations, we gained a deeper insight into how the challenges experienced 
impact on the development of medical device software. The interviews also attempted to learn 
from the participants how they believe the challenges experienced can be overcome. The aim 
of this paper is to explain the methodology used to perform interviews with medical device 
software organisations and to present these interviews. 
Keywords 
Medical Device, FDA, Agile, V-Model, Software Development Life Cycle, Semi-Structured In-
terview 
1 Introduction 
Medical device software organisations experience difficulties not experienced by non-regulated soft-
ware development organisations. Anecdotal evidence suggests the biggest challenge experienced by 
medical device software organisations is regulatory controls. Medical device software, regardless of 
the time or money spent on the development of the software, can be deemed useless if it fails to 
achieve regulatory approval. Medical device software organisations therefore may be reluctant to 
adopt new techniques to improve efficiencies, fearing that it may hinder their chances of achieving 
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regulatory approval. Ongoing research will present practices to medical device organisations which 
aim to achieve efficiencies without hindering the process of securing regulatory approval.  
 To learn the areas in which difficulties are experienced semi structured interviews were con-
ducted with medical device software organisations. These interviews gave an insight into the real diffe-
rences between developing medical device software and generic software and also the challenges 
faced by these organisations. Once this understanding was gained, appropriate recommendations can 
be made as to how these challenges may be overcome and efficiencies can be successfully introdu-
ced.  
The remainder of this paper is structured as follows, Section 2 discusses the methodology 
used to create the interviews, Section 3 presents the participants of the interviews, Section 4 outlines 
the findings of the interviews, Section 5 discusses the recommendations and in Section 6 the conclu-
sions are presented.   
2 Research Methodology 
The interviews were conducted in accordance with Wengraf [1]. The interviews were performed on a 
semi structured basis. This form of interview is known as a Semi Structured Depth Interview (SSDI). 
SSDIs are characterized by the following features: 
 
• “The interview is a research interview, designed for the purpose of improving knowledge. 
• It is a special type of conversational interaction: in some ways it is like other conversations, but it has 
special features which need to be understood. 
• It has to be planned and prepared for like other forms of research activity but what is planned is a de-
liberate half-scripted or quarter-scripted interview: its questions are only partially prepared in advance 
and will therefore be largely improvised by you as an interviewer. But only largely: the interview as a 
whole is a joint production, a co-production, by you and your interviewee. 
• It is to go into matters ‘in depth’”. [1]  
SSDIs are further categorized into two classifications, Heavily Structured Depth Interviews and Lightly 
Structured Depth Interviews.  The degree of structuring is determined by the degree to which the 
questions and interventions are pre-prepared by the researcher. Figure 1 shows the relationship bet-
ween structured and unstructured interviews.   
 
2.1 Pyramid Model 
In accordance with Wengraf, the interview was broken into four elements. These elements are: 
• Research Purposes (RP); 
• Central Research Question(s) (CRQ); 
• Theory Questions (TQ); 
• Interview Interventions (II) / Interview Questions (IQ). 
a ◘ŕś▄-. ĵ ╜▄ŕ ╜■┼ 
Ç╙ś◘ŉŦ-. ĵ ╜▄ŕ╜■┼ 
a ◘ŕś▄-Çśℓĕ■┼ 
Ç╙ś◘ŉŦ-Çśℓĕ■┼ 
Ü■ℓêŉĵ ľêĵ ŉśŕ  Cĵ ▄▄Ŧ {êŉĵ ľ êĵ ŉśŕ  [ ╜┼╙ê▄Ŧ ℓêŉĵ ľ êĵ ŉśŕ  I śĂō╜▄Ŧ ℓêŉĵ ľêĵ ŉśŕ  
Figure 1 Spectrum from Unstructured to Fully Structured Interviewing, and Possible Relationship to  
Phases in the Development of a Theory [1] 
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The RP is the motivation behind the research being conducted. For this research, the RP is to gain a 
deeper insight into difficulties experienced when developing medical device software. The CRQ is the 
primary question(s) to which answers are being sought as a result of the interview being conducted. 
The TQ are high level questions. These questions are not asked directly to the interview participant. 
TQ are used to formulate the actual questions that will be asked of the participant. II/IQ is what is ac-
tually asked of the participant during the interview. The information gleaned from the responses is 
compiled to answer the TQ which in turn answer the CRQ which ultimately supports the RP. The rela-
tionship between each of these elements is shown in the pyramid model shown in figure 2. 
In Dillon [3], the author discusses the various types of questions and non-questions in inter-
view scenarios. He describes that interventions1 in an interview can be more beneficial than pre-
prepared questions. As a result they are included in the pyramid model. 
3 Interview Participants 
A difficulty often associated with SSDI’s is the process of achieving representative sampling. Patton [4] 
presents several different sampling methods used as part of conducting SSDI’s each valid to specific 
methods of research. This is known as Patton’s Typology of Randomised and Purposive Sampling [4]. 
Based upon Patton’s Typology of Randomised and Purposive Sampling the most appropriate method 
of sampling for this research is “Purposeful Sampling” employing “Maximum Variation Sampling”. 
Using this approach, organisations of varying structure and size each of which representing a sector of 
the medical device software development industry were identified. 
 Seven medical device software organisations participated in the interviews. Within each orga-
nisation, employees best placed to answer questions relating to the development of medical device 
software were interviewed. The positions which these employees hold within the different organisati-
ons varied. Below is the list of roles which the participants perform:  
• Chief Technical Officer; 
• Head of Development; 
• Quality Manager; 
• Co-Founder/Director; 
• Senior Research and Development; 
• Principal Engineer; 
• Chief Executive Officer; 
• Electronic Design Engineer. 
 
In accordance with Wengraf the following questions i.e. IQ, were established prior to the interviews 
being conducted. The following tables show how each of the IQ relates to a TQ and in turn how the 
TQ contributes to answering the CRQ. The CRQ for this research is “How does the development of 
medical device software differ to the development of non-regulated software?” 
                                                     
1
 Interview Interventions are described as questions or statements made during the interview to elicit 
responses that are not prepared prior to the interview. 
Figure 2 CRQ > TQ > IQ/II: Pyramid Model [1] 
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Table 1 Research Questions 
 
 
 
 
 
 
 
 
Table 2 Theory Questions 
IQ1a. RQ1 TQ1 Does regulatory conformance directly impact the development of medical software? IQ1b. 
IQ2a. TQ2 Are you following a Plan-Driven software deve-
lopment lifecycle and if so why? IQ2b. 
IQ3a. TQ3 Does following a Plan-Driven software develop-
ment lifecycle meet all of the organisation and regulato-
ry requirement? IQ3b. 
IQ4a. 
CRQ 
RQ2 
TQ4 Would a tailored lifecycle be more appropriate 
than moving to a different software development lifecyc-
le completely? IQ4b. 
Table 3 Interview Questions 
IQ1a. How do you believe the development of medical 
device software differs to that of the development of 
generic software? RQ1 TQ1 
IQ1b. How do these differences impact on the deve-
lopment of medical device software? 
IQ2a. For your current software development project 
which software development lifecycle are you follo-
wing? TQ2 
IQ2b. Why are you following this lifecycle? 
IQ3a. What difficulties are you experiencing as part of 
your current software development project? TQ3 IQ3b. Why do you believe you are having these prob-
lems? 
IQ4a. Do you believe there is a way to overcome these 
problems? 
CRQ 
RQ2 
TQ4 IQ4b. What do you believe are the barriers to moving 
away from your current software development lifecycle? 
4 Interview Findings 
The interviews conducted yielded rich qualitative data. However, a method was needed to extract the 
findings from this qualitative data. The results of the interviews were analyzed in accordance with 
Wengraf’s, Interview Material to Answers to Theory Questions to an Answer to the Central Research 
Question (IM-ATQ-ACRQ) model [1]. Whilst the CRQ > TQ > IQ/II model utilizes a top down approach, 
the IM-ATQ-ACRQ model utilizes a bottom up approach to determine the answer to the central re-
search question. This method was used as it complimented the method employed for the creation of 
the interview questions i.e. RP > CRQ > TQ > IQ/II. The results were also analysed in accordance with 
Miles and Huberman’s [2] method of analyzing qualitative data.  
4.1 Qualitative Data Analysis 
Miles and Huberman [2] present three stages for qualitative data analysis. The three stages are: 
• Data Reduction; 
• Data Display; 
• Conclusion Drawing and Verification. 
IQ1a. RQ1 What are the issues with developing medical devi-
ce software? TQ1 IQ1b. 
IQ2a. TQ2 IQ2b. 
IQ3a. TQ3 IQ3b. 
IQ4a. 
CRQ RQ2 What are the issues with developing medical devi-
ce software using a traditional software development 
lifecycle? 
TQ4 IQ4b. 
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The relationship between these stages of qualitative data analysis and data collection is shown in 
Figure 2.  
4.1.1 Data Reduction  
SSDIs produce a large amount of data. To navigate all of the data collected the volume must be redu-
ced. Data reduction is a continuous process happening before the data is collected. Before data col-
lection occurs “Anticipatory Reduction” takes place. The interviewer attempts to pre-empt the informa-
tion being collected and selects questions in an attempt to reduce unnecessary information from being 
collected.   
4.1.2  Data Display 
As SSDIs can produce large amounts of raw data, in this case over 30 pages of interview transcripts, 
a method was required in which this data can be displayed in a form easily understood by a person. 
To achieve this matrices and graphs were employed. A key element of data display is that data dis-
play is not separate from data analysis. In fact, it is part of overall process of data analysis [2]. 
4.1.3 Conclusions Drawing and Verification 
The process of drawing conclusions involves examining the collected data and analyzing the implica-
tions this data has on the research being conducted. Miles and Huberman [2] discuss that, whilst a 
final conclusion is created once all of the collected data has been analyzed, conclusions appear very 
early on in the data collection process and that whilst the conclusions may appear to be established 
inductively, external influences can have an impact on the development of early conclusions. Conc-
lusions can be derived from analyzing data once. These conclusions are verified by analyzing the 
data multiple times. The conclusions are deemed to be verified once the results after each analysis 
are the same. 
4.2 Results 
After each of the three stages of qualitative data analysis were performed as outlined in the previous 
section, the results were produced (See table 4). The number sequence after each response correla-
tes to a specific interview and at which point in the interview the response was given.  
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Figure 2 Components of Data Analysis: Interactive Model [2, p.12] 
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RESPONSES RECEIVED 
There is a level of authorisation surrounding the developing of medical device software which adds a certain amount of complexity 
[6,015].Production of clinical evidence, being ISO 13485 compliant and following IEC 62304, production of documentation [5,008,012] [1,008] 
[3,004] [2,002] [7,0034]Risk [4, 002] [1,008] [3,004] 
Safety [1,008]Prescribed set of deliverables before you start [3,004] Usability [3,004] Process is more strict [2,002] 
If you have the right processes in place and you built it into the company it wouldn’t take as long as it currently does for us [5,016]  The cost asso-
ciated with making sure the traceability is current all of the way through [4,004] Increased processes infrastructure required  and you need to have 
a disciplined approach [1,020] Large effort put into testing, integration and validation [3,006]Increased time to market, improved quality more ex-
pensive to produce [2,006, 008] [7,008] 
Waterfall Model [6,021] [1,024] V-Model [5,022] [4,006] [3,014] [2,012] [7,016] 
Residue from some of the activities we performed in the automotive industry [4,009] The majority of our customers have asked us to do it [1,028] 
Auditors are familiar with the V-Model, document outputs are in line with guidance and regulations [2,014] [7,018] 
Requirements Changes [6, 031] Validation is probably something and making sure test cases are linked back to the requirements [4,011] Interde-
pendency between stages and impact on other areas [2,015] Requirements or design, retrofitting or filling gaps [1,034] Traceability of require-
ments [3,0028] [7,022] 
We don’t have a strong enough structured approach and we cannot formalise the requirements capture [4,013] It wasn’t specified up-front [1,040] 
Work better up front on capturing requirements precisely [1,042] Modifying the quality management system [3,032] Improve requirements man-
agement up front [2,018] combine life cycles i.e. agile and Plan-Driven [7,026] 
No barriers at present [6,037] We chose the V-model as it best reflects our processes but we could move away from it [5, 036] Yes, our clients 
would struggle to understand and it would be difficult to quote on an agile project [4,15] I think the barriers would come from key stakeholders 
[1,046] We wouldn’t have a problem making a change and introducing a new system to get over what difficulties we come across [3,032] Increase 
cost in retraining staff and redefining new processes [2,020] [7,028] 
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5 Discussion 
Based upon the findings shown in table 4, it can be seen that the organisations involved identified a 
number of the same problems and challenges as shown by the multiple number sequences after spe-
cific responses. The two most cited difficulties are regulatory constraints and managing requirements 
changes. 
5.1 Regulatory Constraints 
Software developed for use, in or as a medical device must adhere to strict regulatory controls. These 
controls are put in place to ensure the safe and reliable functioning of the software. Medical device 
software organisations must provide objective evidence to regulatory bodies that their device is safe. 
This evidence is achieved through the production of comprehensive documentation. The production of 
this documentation can become burdensome for software organisations. One of the interview partici-
pants noted that whilst the production of documentation and adherence to regulations can be burden-
some, it can also be beneficial. The burden of adherence can act as a barrier to entry into the medical 
device software development industry potentially reducing the amount of competition within the medi-
cal device industry.     
 To accompany the requirements to produce adequate documentation, medical device manu-
facturers are advised to adhere to a quality management standard such as ISO 13485 [5] when deve-
loping medical device software. Whilst in Europe, it is not mandatory to follow this standard, should a 
device manufacturer choose not to follow this standard, they must prove to the regulatory bodies that 
the method which they used to ensure the quality of their device is equally comparable to ISO 13485.  
 The interviews showed that medical device software organisations typically follow a Plan-
Driven Software Development Life Cycle (SDLC) such as the V-Model. Plan-Driven SDLCs produce 
the necessary deliverables required when seeking regulatory conformance; however, Plan-Driven 
SDLCs are not seen as efficient [6] and can be difficult to apply to a medical device software deve-
lopment project in a practice. Section 5.2 discusses how these Plan-Driven SDLCs can be modified to 
become more efficient whilst still producing the necessary regulatory deliverables.  
5.2 Managing Requirements  
Previous research [7, 8] and the interviews conducted as part of this paper has shown that medical 
device software is typically developed in accordance with a Plan-Driven SDLC. Plan-Driven SDLCs 
such as the Waterfall and V-Model are typically performed in a sequential manner with very little scope 
for revisiting stages. Plan-Driven SDLCs dictate that requirements are gathered up-front prior to any 
development beginning. However, a medical device software development project can potentially take 
a number of years to be completed and it can be very difficult to ensure that there will be no change in 
requirements throughout this period. 
 Each of the organisations involved in the interviews identified that a major problem they expe-
rience is accommodating changes once development has begun. To accommodate changes a num-
ber of stages may need to be revisited, having a knock-on effect of increasing rework and therefore 
increasing cost. When asked in the interviews how to resolve the problems associated with changing 
requirements a number of responses were given. One organisation suggested the establishment of an 
incubation period prior to the requirements analysis stage. This incubation period would allow the cus-
tomer time to consider all potential features they wished to include in the software and ideally remov-
ing the need for a change to be implemented once the project has begun. Another organisation sug-
gested placing greater emphasis on up-front planning and again making sure all of the necessary re-
quirements were captured. One organisation suggested “placing manners on the customer” and pre-
venting them from introducing a change once development has begun.  
Each of these suggestions has their own merit, however these are proactive steps, none of the 
organizations were able to suggest a reactive response to when a requirements change was unavoid-
able. Current Plan-Driven SDLCs are rigid and therefore have difficulty accommodating a change. 
Typically, when a change is introduced, a number of stages of development need to be revisited to 
Session I: Session title will be inserted by editors 
1.8 − EuroSPI 2013  
accommodate the change. This can require a lot of rework therefore increasing cost and development 
time. Agile practices and methodologies promote the ability to be able to accommodate changes. The 
agile manifesto states “welcoming changing requirements, even late in development” [9].  This would 
suggest that utilising agile practices in the development of software could offer the “silver bullet” to 
problems associated with late changes in requirements.  
However, research [10-12] has shown that it is very difficult to fully adopt a single agile meth-
odology such as Scrum or XP, as no single agile methodology produces the necessary deliverables 
required when seeking regulatory approval. To overcome this, research suggests that combing agile 
practices with a Plan-Driven SDLC can reap the most significant rewards as the organisation would 
still benefit from the structure associated with following a Plan-Driven approach whilst also gaining the 
efficiencies associated with utilising agile practices. 
6 Conclusions 
Medical device software organisations face challenges not faced by non-regulated software develop-
ment organisations. We conducted interviews with seven medical device software organisations to 
gain a deeper insight into these challenges. We selected organisations of varying size, structure and 
criticality to act as a broader representation of the medical device software industry as a whole. These 
organisations included medical device manufacturers, software suppliers to medical device manufac-
turers and organisations providing design services to medical device software suppliers and manufac-
turers. Whilst these organisations ranged in maturity, size and software criticality, the challenges expe-
riences by each of them are very similar. The biggest challenge identified is the adherence to regulato-
ry controls. This adherence brings with it the overhead associated with producing large amounts of 
documentation. It also brings with it the perception that following a Plan-Driven SDLC is required in 
order produce the necessary deliverables required when seeking regulatory approval2.  
The CRQ of this research is to determine the differences between the development of medical 
device software and the development of non-regulated software. The interviews revealed that the key 
difference is the need to adhere to regulatory controls. Regulatory controls appear to restrict medical 
device software organisations to follow a sequential plan driven SDLC. However, following a plan-
driven SDLC can introduce problems such as having difficulties introducing requirements changes. 
As medical device software is typically developed in accordance with a Plan-Driven SDLC, 
medical device software organisations experience the inherent problems associated with following this 
type of lifecycle. The most identified challenge by the participants of the interviews associated with 
following a Plan-Driven SDLC is accommodating requirements changes. As Plan-Driven SDLC are 
completed in a sequential manner, if a stage is completed and development has moved on it can be 
very difficult to revisit a stage such as “Requirements Management”.  
 To overcome this challenge, medical device software organisations are advised to move to a 
SDLC which can better accommodate requirements changes. Agile methodologies boast the ability to 
welcome changes throughout the development lifecycle. However, research has shown that it can be 
very difficult to fully move away from a Plan-Driven SDLC to an agile methodology as no single agile 
methodology produces the necessary regulatory deliverables. Based on this, future work as part of 
this research will involve developing and validating a hybrid SDLC which combines a Plan-Driven 
SDLC with agile practices to introduce efficiencies and to overcome the difficulties associated with 
requirements management in medical device software development projects. 
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